VentriPoint Diagnostics Ltd. (VPTDF)
USD 0.07
(-2.72%)
USD 0.07
(-2.72%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.8 Million | -4.13 Million | -3.14 Million | -1.1 Million | -2.38 Million | -3.04 Million |
| Net Income | -4.87 Million | -4.87 Million | -3.88 Million | -1.85 Million | -3.32 Million | -2.08 Million |
| Depreciation & Amortization | 66.66 Thousand | 50.9 Thousand | 48.81 Thousand | 54.94 Thousand | 60.31 Thousand | 28.28 Thousand |
| Deferred income taxes | - | - | 276.19 Thousand | -26.87 Thousand | -78.5 Thousand | -1.74 Million |
| Stock-based compensation | 493.3 Thousand | 798.05 Thousand | 898.3 Thousand | 394.84 Thousand | 272.6 Thousand | 640.35 Thousand |
| Change in working capital | 452.36 Thousand | -331.06 Thousand | -462.58 Thousand | 122.98 Thousand | 477.86 Thousand | 103.96 Thousand |
| Other non-cash items | 308.33 Thousand | 218.16 Thousand | -26.45 Thousand | 204.42 Thousand | 276.55 Thousand | 210.02 Thousand |
| Investing Cash Flow | - | - | -4257.00 | -3763.00 | -17.09 Thousand | -27.37 Thousand |
| Investments in PPE | - | - | -4257.00 | -3763.00 | -17.09 Thousand | -27.37 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -102.35 Thousand | 87.64 Thousand | 11.89 Million | 1.62 Million | 2.34 Million | 1.83 Million |
| Debt repayment | -102.35 Thousand | -50.7 Thousand | -48.86 Thousand | -13.16 Thousand | -46.37 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 138.35 Thousand | 8.05 Million | 530.8 Thousand | 703.07 Thousand | 1.86 Million |
| Other Financing Activities | -24.45 Thousand | 138.35 Thousand | 3.88 Million | 1.1 Million | 1.68 Million | -28.26 Thousand |
| Accounts receivables | 88.67 Thousand | -176.68 Thousand | -32.15 Thousand | -97.68 Thousand | 12.56 Thousand | 19.58 Thousand |
| Accounts payables | 285.33 Thousand | -86.76 Thousand | -396.04 Thousand | 145.59 Thousand | 336.37 Thousand | 143.94 Thousand |
| Inventory | - | 176.68 Thousand | 32.15 Thousand | 30.82 Thousand | 38.16 Thousand | -18.4 Thousand |
| Other working capital | 78.35 Thousand | -244.3 Thousand | -66.53 Thousand | 44.25 Thousand | 90.75 Thousand | -41.15 Thousand |
| Cash at beginning of period | 5.18 Million | 9.26 Million | 526.02 Thousand | 13.76 Thousand | 66.56 Thousand | 1.35 Million |
| Cash at end of period | 1.29 Million | 5.18 Million | 9.26 Million | 526.02 Thousand | 13.76 Thousand | 66.56 Thousand |
| Capital Expenditure | - | - | -4257.00 | -3763.00 | -17.09 Thousand | -27.37 Thousand |
| Effect of forex changes on cash | 14.82 Thousand | -34.1 Thousand | 3488.00 | -4502.00 | 1575.00 | -52.48 Thousand |
| Net cash flow / Change in cash | -3.89 Million | -4.08 Million | 8.74 Million | 512.26 Thousand | -52.8 Thousand | -1.29 Million |
| Free Cash Flow | -3.8 Million | -4.13 Million | -3.15 Million | -1.1 Million | -2.39 Million | -3.07 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.41 Million | -1.18 Million | -4.87 Million | -1.23 Million | -1.17 Million | -1.11 Million |
| Depreciation & Amortization | 15.74 Thousand | 16.17 Thousand | 66.66 Thousand | 16.66 Thousand | 16.55 Thousand | 16.64 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 82.72 Thousand | 53.5 Thousand | 493.3 Thousand | 100.6 Thousand | 108.34 Thousand | 113.23 Thousand |
| Change in working capital | 187.11 Thousand | 238.85 Thousand | 452.36 Thousand | 114.81 Thousand | 65.35 Thousand | 25.74 Thousand |
| Other non-cash items | 69.51 Thousand | 17.33 Thousand | 308.33 Thousand | 17.79 Thousand | 13.8 Thousand | 14.26 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.03 Million | -31.77 Thousand | -102.35 Thousand | -29.39 Thousand | -26.68 Thousand | -32.11 Thousand |
| Debt repayment | -1.06 Million | -69.39 Thousand | -102.35 Thousand | -29.39 Thousand | -26.68 Thousand | -32.11 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 37.62 Thousand | - | - | - | - |
| Other Financing Activities | -8151.00 | -48.15 Thousand | -24.45 Thousand | -8151.00 | -5434.00 | -10.86 Thousand |
| Accounts receivables | 77.57 Thousand | 76.17 Thousand | 88.67 Thousand | -18.23 Thousand | -39.24 Thousand | -8963.00 |
| Accounts payables | 111.58 Thousand | 67.85 Thousand | 285.33 Thousand | 147.62 Thousand | 118.59 Thousand | -5602.00 |
| Inventory | - | - | - | - | 39.24 Thousand | 5602.00 |
| Other working capital | 109.53 Thousand | 162.67 Thousand | 78.35 Thousand | -14.57 Thousand | -53.23 Thousand | 34.71 Thousand |
| Cash at beginning of period | 375 Thousand | 1.29 Million | 5.18 Million | 2.3 Million | 3.31 Million | 4.27 Million |
| Cash at end of period | 305.61 Thousand | 375 Thousand | 1.29 Million | 1.29 Million | 2.3 Million | 3.31 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -4647.00 | -14.3 Thousand | 14.82 Thousand | 12.11 Thousand | -9788.00 | 12.05 Thousand |
| Net cash flow / Change in cash | -69.39 Thousand | -919.33 Thousand | -3.89 Million | -1 Million | -1 Million | -965.36 Thousand |
| Free Cash Flow | -1.1 Million | -873.25 Thousand | -3.8 Million | -991.77 Thousand | -970.22 Thousand | -945.3 Thousand |
BANX
6163
2001
BRKM5
6943
1613